Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Association of Race, Ethnicity, and Social Deprivation on the Incidence and Severity of Adverse Events in Induction in Children with Acute Lymphoblastic Leukemia

Jason M Stevenson, Anjali Khanna, Ashleigh Hawk, Avery Morse, Oyin Alao, Katherine Jordan, Xu Ji, Heeju Sohn, Sharon M. Castellino, Tamara P. Miller

Blood (2024) 144 (Supplement 1): 5110.

https://doi.org/10.1182/blood-2024-205766

Published: 2024

Journal Articles

Acuity of Illness at Initial Presentation Mediates Early Mortality in Adolescent and Young Adult Leukemia

Tarun Jain, Xu Ji, Nicholas Degroote, Alexandra Himes, Cortland Coxhead, Rebecca Williamson Lewis, Anjali Khanna, Alexandra Cathcart, Tamara P. Miller, Kristie A. Blum, Keiko Tarquinio, Sharon M. Castellino

Blood (2024) 144 (Supplement 1): 2347.

https://doi.org/10.1182/blood-2024-209796

Published: 2024

Journal Articles

Understanding the Associations between High-Dose Methotrexate Pharmacokinetics and the Risk of Adverse Events in Children and Adolescents with Down Syndrome Associated High-Risk Acute Lymphoblastic Leukemia

Kate D. Westmoreland, Zachary L Taylor, Tamara P. Miller, Ashley Chavana, Karen R Rabin, Austin L Brown, Melanie Brooke Bernhardt, Eric S. Schafer, Maureen M. O'Brien, Sharon M. Castellino, Laura B. Ramsey

Blood (2024) 144 (Supplement 1): 1438.

https://doi.org/10.1182/blood-2024-211870

Published: 2024

Journal Articles

Residential Economic and Racial Segregation Is Associated with Acuity and Severity of Pediatric Leukemia at Presentation

Xu Ji, Rebecca Williamson Lewis, Tarun Jain, Lu Zhang, Sharon M. Castellino

Blood (2024) 144 (Supplement 1): 3735.

https://doi.org/10.1182/blood-2024-205951

Published: 2024

Journal Articles

Assessing the Impact of Digital Education on the Clinical Management of Rare Hematologic Malignancies

Tisheeka Graham, Tariqa Ackbarali, Katie Kowalski, Sharon M. Castellino, Lisa Giulino Roth, Matthew J. Ehrhardt, Matthew Matasar

Blood (2024) 144 (Supplement 1): 7794.

https://doi.org/10.1182/blood-2024-211680

Published: 2024

Journal Articles

Pembrolizumab in Children, Adolescents, and Young Adults with Low-Risk Classic Hodgkin Lymphoma (cHL) and Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Blood (2024) 144 (Supplement 1): 462.

https://doi.org/10.1182/blood-2024-199263

Published: 2024

Journal Articles

Impact of Survivorship Care Plans (SCP) on Mortality in a Contemporary Cohort of Pediatric Patients Diagnosed with a Blood Cancer

Sharon M. Castellino, Rebecca Williamson Lewis, Karen E Effinger, Ann C. Mertens, Joseph Lipscomb, Xu Ji

Blood (2023) 142 (Supplement 1): 3790.

https://doi.org/10.1182/blood-2023-177962

Published: 2023

Journal Articles

Health Insurance Continuity Is Associated with Stage at Diagnosis Among Children, Adolescents, and Young Adults Newly Diagnosed with Lymphoma

Xinyue Zhang, Sharon M. Castellino, K. Robin Yabroff, Wendy Stock, Shasha Bai, Ann C. Mertens, Joseph Lipscomb, Xu Ji

Blood (2023) 142 (Supplement 1): 2390.

https://doi.org/10.1182/blood-2023-179559

Published: 2023

Journal Articles

Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results from the Phase 2 Keynote-667 Study

Blood (2023) 142 (Supplement 1): 1700.

https://doi.org/10.1182/blood-2023-186719

Published: 2023

Journal Articles

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Lianna J. Marks, Kathleen McCarten, Qinglin Pei, Yue Wu, Kara M. Kelly, Cindy Schwartz, Suzanne Wolden, Debra L. Friedman, Sharon M. Castellino, Burton Appel

Blood (2023) 142 (Supplement 1): 1699.

https://doi.org/10.1182/blood-2023-179465

Published: 2023

Journal Articles

Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study

Annalynn M Williams, Angie Mae Rodday, Qinglin Pei, Tara O. Henderson, Frank Keller, Angela Punnett, Kara M. Kelly, Sharon M. Castellino, Susan K Parsons

Blood (2023) 142 (Supplement 1): 672.

https://doi.org/10.1182/blood-2023-187125

Published: 2023

Journal Articles

Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods

Blood (2023) 142 (Supplement 1): 177.

https://doi.org/10.1182/blood-2023-186810

Published: 2023

Journal Articles

Association of Age with Acuity and Severity of Illness at Initial Presentation in Children, Adolescents, and Young Adults with Leukemia

Tarun Jain, Xu Ji, Nicholas Degroote, Alexandra Himes, Cortland Coxhead, Anjali Khanna, Alexandra Cathcart, Tamara P. Miller, Kristie A. Blum, Keiko Tarquinio, Ann C. Mertens, Sharon M. Castellino

Blood (2023) 142 (Supplement 1): 3769.

https://doi.org/10.1182/blood-2023-189967

Published: 2023

Journal Articles

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

Blood (2023) 142 (Supplement 1): 610.

https://doi.org/10.1182/blood-2023-180107

Published: 2023

Journal Articles

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Blood (2023) 142 (Supplement 1): 3084.

https://doi.org/10.1182/blood-2023-189652

Published: 2023

Journal Articles

CNS Involvement in Pediatric Hodgkin Lymphoma: A Comprehensive Retrospective Analysis from the Staging, Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL) Group

Reena Pabari, Kathleen McCarten, Jamie E. Flerlage, Hollie Lai, Christine Mauz-Koerholz, Karin Dieckmann, Monica Palese, Sue Caste, Sharon M. Castellino, Kara M. Kelly, Dietrich Stoevesandt, Lars Kurch

Blood (2023) 142 (Supplement 1): 3066.

https://doi.org/10.1182/blood-2023-187921

Published: 2023

Journal Articles

Identifying Tumor-Specific Immune Response and Biomarkers of High-Risk Hodgkin Lymphoma Patients Treated with and without Brentuximab on Children's Oncology Group Trial AHOD1331

Keri Toner, Hema Dave, Gloria Pezzella, Qinglin Pei, Terzah M. Horton, Kara M. Kelly, Lisa Giulino Roth, Sharon M. Castellino, Catherine M. Bollard

Blood (2023) 142 (Supplement 1): 4383.

https://doi.org/10.1182/blood-2023-180791

Published: 2023

Journal Articles

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

Blood (2023) 142 (Supplement 1): 181.

https://doi.org/10.1182/blood-2023-180114

Published: 2023

Journal Articles

A Single Cell Atlas and Interactive Web-Resource of Pediatric Cancers and Healthy Bone Marrow

Hope L Mumme, Swati S Bhasin, Mariam Nawaz, Beena E Thomas, Chenbin Huang, Deborah DeRyckere, Sharon M. Castellino, Daniel S. Wechsler, Sunil S. Raikar, Christopher C. Porter, Douglas K Graham, Manoj Bhasin

Blood (2022) 140 (Supplement 1): 2278–2279.

https://doi.org/10.1182/blood-2022-169153

Published: 2022

Journal Articles

Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas

Blood (2022) 140 (Supplement 1): 1318–1319.

https://doi.org/10.1182/blood-2022-159230

Published: 2022

NARROW

Association of Race, Ethnicity, and Social Deprivation on the Incidence and Severity of Adverse Events in Induction in Children with Acute Lymphoblastic Leukemia

Acuity of Illness at Initial Presentation Mediates Early Mortality in Adolescent and Young Adult Leukemia

Understanding the Associations between High-Dose Methotrexate Pharmacokinetics and the Risk of Adverse Events in Children and Adolescents with Down Syndrome Associated High-Risk Acute Lymphoblastic Leukemia

Residential Economic and Racial Segregation Is Associated with Acuity and Severity of Pediatric Leukemia at Presentation

Assessing the Impact of Digital Education on the Clinical Management of Rare Hematologic Malignancies

Pembrolizumab in Children, Adolescents, and Young Adults with Low-Risk Classic Hodgkin Lymphoma (cHL) and Slow Early Response to Front-Line Chemotherapy: Updated Results from the Phase 2 Keynote-667 Study

Impact of Survivorship Care Plans (SCP) on Mortality in a Contemporary Cohort of Pediatric Patients Diagnosed with a Blood Cancer

Health Insurance Continuity Is Associated with Stage at Diagnosis Among Children, Adolescents, and Young Adults Newly Diagnosed with Lymphoma

Pembrolizumab (pembro) in Children and Young Adults with Low-Risk Classical Hodgkin Lymphoma (cHL) with Slow Early Response (SER) to Front-Line Chemotherapy (chemo): Early Results from the Phase 2 Keynote-667 Study

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study

Genomic, Transcriptional, and Immunological Validation of Distinct Molecular Subtypes of Classic Hodgkin Lymphoma through Tissue-Based and Noninvasive Methods

Association of Age with Acuity and Severity of Illness at Initial Presentation in Children, Adolescents, and Young Adults with Leukemia

Progression-Free Survival (PFS) and Toxicity with Nivolumab-AVD Compared to Brentuximab Vedotin-AVD in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL), Results of SWOG S1826

AHOD2131: A Randomized Phase 3 Response-Adapted Trial Comparing Standard Therapy with Immuno-Oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

CNS Involvement in Pediatric Hodgkin Lymphoma: A Comprehensive Retrospective Analysis from the Staging, Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL) Group

Identifying Tumor-Specific Immune Response and Biomarkers of High-Risk Hodgkin Lymphoma Patients Treated with and without Brentuximab on Children's Oncology Group Trial AHOD1331

Nivolumab-AVD Is Better Tolerated and Improves Progression-Free Survival Compared to Bv-AVD in Older Patients (Aged ≥60 Years) with Advanced Stage Hodgkin Lymphoma Enrolled on SWOG S1826

A Single Cell Atlas and Interactive Web-Resource of Pediatric Cancers and Healthy Bone Marrow

Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only